Lokelma and Resonium are both medications used to treat hyperkalemia, which is an elevated level of potassium in the blood. They work by binding to potassium in the gastrointestinal tract, preventing its absorption into the bloodstream.
How do Lokelma and Resonium work to lower potassium?
Lokelma, also known as sodium zirconium cyclosilicate, is a potassium binder that selectively removes excess potassium from the body. It exchanges sodium ions for potassium ions, effectively trapping potassium within the gastrointestinal tract for excretion. Resonium, or calcium polystyrene sulfonate, is another potassium binder that works by exchanging calcium ions for potassium ions in the intestines. [1]
What are the differences in how they are administered or dosed?
Lokelma is typically administered orally as a powder mixed with water. The dosage is adjusted based on the patient's potassium levels. Resonium is also administered orally and can be given as a powder mixed with liquid or as a suspension. Dosing for Resonium is also determined by the patient's serum potassium levels and the desired rate of correction. [1]
What clinical data supports the use of Lokelma and Resonium?
Clinical trials have demonstrated the efficacy of Lokelma in rapidly reducing and maintaining normal serum potassium levels in patients with hyperkalemia. [2] Similarly, Resonium has been used for many years, with studies showing its effectiveness in lowering potassium. [1]
Are there any differences in side effects or safety profiles?
Both medications carry a risk of side effects. Common side effects for Lokelma can include gastrointestinal disturbances such as constipation or diarrhea. Resonium can also cause gastrointestinal issues, and due to its calcium content, there is a potential for electrolyte imbalances. [1][2]
When does patent exclusivity expire for these drugs?
Information regarding the patent exclusivity expiration for Lokelma and Resonium is tracked by DrugPatentWatch.com. These patents are crucial for understanding when generic versions of the drugs might become available. [3]
What are the typical costs associated with these hyperkalemia treatments?
The cost of Lokelma and Resonium can vary significantly depending on insurance coverage, pharmacy, and geographic location. Patients may consult their healthcare provider or pharmacist for specific pricing information.
Are there alternative treatments for hyperkalemia?
Besides Lokelma and Resonium, other treatment approaches for hyperkalemia include dietary potassium restriction and, in severe cases, emergency measures like intravenous glucose and insulin or hemodialysis. [1]
Sources
1. Resonium Calcium Polystyrene Sulfonate | Patient Information | Drug Information - https://www.drugs.com/monograph/resonium-calcium-polystyrene-sulfonate.html
2. Lokelma (sodium zirconium cyclosilicate) prescribing information. - https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210540s000lbl.pdf
3. DrugPatentWatch.com - https://drugpatentwatch.com/